TrialDermatology (Basel, Switzerland)2024

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic Dermatitis.

Michael E Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.